491 related articles for article (PubMed ID: 30417428)
1. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
2. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies.
Wetering JV; Geut H; Bol JJ; Galis Y; Timmermans E; Twisk JWR; Hepp DH; Morella ML; Pihlstrom L; Lemstra AW; Rozemuller AJM; Jonkman LE; van de Berg WDJ
Acta Neuropathol Commun; 2024 May; 12(1):73. PubMed ID: 38715119
[TBL] [Abstract][Full Text] [Related]
5. Microglial pathology in Down syndrome.
Xue QS; Streit WJ
Acta Neuropathol; 2011 Oct; 122(4):455-66. PubMed ID: 21847625
[TBL] [Abstract][Full Text] [Related]
6. Identification of a dysfunctional microglial population in human Alzheimer's disease cortex using novel single-cell histology image analysis.
Swanson MEV; Scotter EL; Smyth LCD; Murray HC; Ryan B; Turner C; Faull RLM; Dragunow M; Curtis MA
Acta Neuropathol Commun; 2020 Oct; 8(1):170. PubMed ID: 33081847
[TBL] [Abstract][Full Text] [Related]
7. Presence of severe neuroinflammation does not intensify neurofibrillary degeneration in human brain.
Streit WJ; Xue QS; Braak H; del Tredici K
Glia; 2014 Jan; 62(1):96-105. PubMed ID: 24272705
[TBL] [Abstract][Full Text] [Related]
8. Dystrophic microglia in late-onset Alzheimer's disease.
Streit WJ; Khoshbouei H; Bechmann I
Glia; 2020 Apr; 68(4):845-854. PubMed ID: 31922322
[TBL] [Abstract][Full Text] [Related]
9. Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
Sanchez-Mejias E; Navarro V; Jimenez S; Sanchez-Mico M; Sanchez-Varo R; Nuñez-Diaz C; Trujillo-Estrada L; Davila JC; Vizuete M; Gutierrez A; Vitorica J
Acta Neuropathol; 2016 Dec; 132(6):897-916. PubMed ID: 27743026
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
[TBL] [Abstract][Full Text] [Related]
11. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
[TBL] [Abstract][Full Text] [Related]
12. Microglial immunophenotype in dementia with Alzheimer's pathology.
Minett T; Classey J; Matthews FE; Fahrenhold M; Taga M; Brayne C; Ince PG; Nicoll JA; Boche D;
J Neuroinflammation; 2016 Jun; 13(1):135. PubMed ID: 27256292
[TBL] [Abstract][Full Text] [Related]
13. Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease.
Hayes A; Thaker U; Iwatsubo T; Pickering-Brown SM; Mann DM
Neurosci Lett; 2002 Oct; 331(3):171-4. PubMed ID: 12383924
[TBL] [Abstract][Full Text] [Related]
14. Amylin Treatment Reduces Neuroinflammation and Ameliorates Abnormal Patterns of Gene Expression in the Cerebral Cortex of an Alzheimer's Disease Mouse Model.
Wang E; Zhu H; Wang X; Gower AC; Wallack M; Blusztajn JK; Kowall N; Qiu WQ
J Alzheimers Dis; 2017; 56(1):47-61. PubMed ID: 27911303
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology.
Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT
Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation and common mechanism in Alzheimer's disease and prion amyloidosis: amyloid-associated proteins, neuroinflammation and neurofibrillary degeneration.
Rozemuller AJ; Jansen C; Carrano A; van Haastert ES; Hondius D; van der Vies SM; Hoozemans JJ
Neurodegener Dis; 2012; 10(1-4):301-4. PubMed ID: 22398730
[TBL] [Abstract][Full Text] [Related]
18. Microglial activation in Alzheimer disease: Association with APOE genotype.
Egensperger R; Kösel S; von Eitzen U; Graeber MB
Brain Pathol; 1998 Jul; 8(3):439-47. PubMed ID: 9669695
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic profile of alternative activation marker CD163 is different in Alzheimer's and Parkinson's disease.
Pey P; Pearce RK; Kalaitzakis ME; Griffin WS; Gentleman SM
Acta Neuropathol Commun; 2014 Feb; 2():21. PubMed ID: 24528486
[TBL] [Abstract][Full Text] [Related]
20. Microglia, amyloid and dementia in alzheimer disease. A correlative study.
Arends YM; Duyckaerts C; Rozemuller JM; Eikelenboom P; Hauw JJ
Neurobiol Aging; 2000; 21(1):39-47. PubMed ID: 10794847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
